播放中国国产国语纯一级黄片免费看, 大鸡吧快来啊阿啊阿啊黄片在线播放, 中文精品日韩网站在线观看视频免费, 别揉我奶头~嗯~啊~一区二区三区,AV无码播放一级毛片免费古装,亚洲春色一区二区三区,91大神极品,美国一级大黄一片免费下载,午夜爽爽爽男女免费观看软件

Welcome to LookChem.com Sign In|Join Free

CAS

  • or
3,4-Dibenzyloxybenzaldehyde, with the CAS number 5447-02-9, is an organic compound characterized by its off-white solid appearance. It is widely recognized for its utility in various organic synthesis processes, making it a valuable component in the field of chemistry.

5447-02-9

Post Buying Request

5447-02-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

5447-02-9 Usage

Uses

Used in Organic Synthesis:
3,4-Dibenzyloxybenzaldehyde is used as a key intermediate in the synthesis of various organic compounds. Its unique structure allows it to serve as a building block for the creation of a diverse range of molecules, including pharmaceuticals, agrochemicals, and other specialty chemicals.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 3,4-Dibenzyloxybenzaldehyde is utilized as a starting material for the development of new drugs. Its reactivity and structural versatility make it an ideal candidate for the synthesis of complex molecular structures with potential therapeutic applications.
Used in Flavor and Fragrance Industry:
3,4-Dibenzyloxybenzaldehyde also finds application in the flavor and fragrance industry, where it is employed to create unique and distinct scents for various products. Its chemical properties enable it to contribute to the development of novel fragrances and flavor profiles.
Used in Dye and Pigment Industry:
In the dye and pigment industry, 3,4-Dibenzyloxybenzaldehyde is used as a precursor for the production of various dyes and pigments. Its chemical structure allows for the creation of vibrant and stable colorants that are used in a wide range of applications, from textiles to plastics.
Used in Research and Development:
3,4-Dibenzyloxybenzaldehyde is also an important compound in research and development, where it is used to study various chemical reactions and mechanisms. Its unique properties make it a valuable tool for understanding the behavior of different molecules and their interactions with other compounds.

Check Digit Verification of cas no

The CAS Registry Mumber 5447-02-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,4,4 and 7 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 5447-02:
(6*5)+(5*4)+(4*4)+(3*7)+(2*0)+(1*2)=89
89 % 10 = 9
So 5447-02-9 is a valid CAS Registry Number.
InChI:InChI=1/C19H14O3/c20-14-15-11-12-18(21-16-7-3-1-4-8-16)19(13-15)22-17-9-5-2-6-10-17/h1-14H

5447-02-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 3,4-Dibenzyloxybenzaldehyde

1.2 Other means of identification

Product number -
Other names Benzaldehyde, 3,4-bis(phenylmethoxy)-

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:5447-02-9 SDS

5447-02-9Synthetic route

benzyl chloride
100-44-7

benzyl chloride

3,4-dihydroxybenzaldehyde
139-85-5

3,4-dihydroxybenzaldehyde

3,4-dibenzyloxybenzaldehyde
5447-02-9

3,4-dibenzyloxybenzaldehyde

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 120℃; for 15h;100%
With potassium carbonate In N,N-dimethyl-formamide at 120℃; for 15h;99%
With potassium carbonate In N,N-dimethyl-formamide at 20 - 130℃; for 4h;96%
benzyl bromide
100-39-0

benzyl bromide

3,4-dihydroxybenzaldehyde
139-85-5

3,4-dihydroxybenzaldehyde

3,4-dibenzyloxybenzaldehyde
5447-02-9

3,4-dibenzyloxybenzaldehyde

Conditions
ConditionsYield
With potassium carbonate In acetone at 80℃; for 6h;97.4%
With potassium carbonate In acetonitrile for 24h; Reflux;96%
With potassium carbonate In acetonitrile for 24h; Reflux;96%
benzyl bromide
100-39-0

benzyl bromide

3,4-dihydroxybenzaldehyde
139-85-5

3,4-dihydroxybenzaldehyde

A

3,4-dibenzyloxybenzaldehyde
5447-02-9

3,4-dibenzyloxybenzaldehyde

B

4-benzyloxy-3-hydroxy-benzaldehyde
4049-39-2

4-benzyloxy-3-hydroxy-benzaldehyde

Conditions
ConditionsYield
With potassium carbonate; potassium iodide In acetone for 72h; Inert atmosphere; Reflux;A n/a
B 93%
Stage #1: 3,4-dihydroxybenzaldehyde With sodium hydride In N,N-dimethyl-formamide; mineral oil at 0℃; for 0.5h; Inert atmosphere;
Stage #2: benzyl bromide In N,N-dimethyl-formamide; mineral oil at 0℃; for 6h; Inert atmosphere; regioselective reaction;
C23H24O4

C23H24O4

3,4-dibenzyloxybenzaldehyde
5447-02-9

3,4-dibenzyloxybenzaldehyde

Conditions
ConditionsYield
With water In methanol at 25 - 30℃; for 0.333333h;92%
3,4-bis(phenylmethoxy)-benzonitrile
253336-68-4

3,4-bis(phenylmethoxy)-benzonitrile

3,4-dibenzyloxybenzaldehyde
5447-02-9

3,4-dibenzyloxybenzaldehyde

Conditions
ConditionsYield
With diisobutylaluminium hydride In toluene at -78℃; Inert atmosphere;92%
With diisobutylaluminium hydride In toluene at -78℃; for 3.5h;92%
1,2-bis(benzyloxy)-4-(bromomethyl)benzene
150258-69-8

1,2-bis(benzyloxy)-4-(bromomethyl)benzene

3,4-dibenzyloxybenzaldehyde
5447-02-9

3,4-dibenzyloxybenzaldehyde

Conditions
ConditionsYield
With trihexyl (tetradecyl) phosphonium tetrafluoroborate; dihydrogen peroxide In water at 50℃; for 0.5h; Inert atmosphere;90%
acetic acid acetoxy-(3,4-bis-benzyloxy-phenyl)-methyl ester

acetic acid acetoxy-(3,4-bis-benzyloxy-phenyl)-methyl ester

3,4-dibenzyloxybenzaldehyde
5447-02-9

3,4-dibenzyloxybenzaldehyde

Conditions
ConditionsYield
β‐cyclodextrin In methanol; water at 60℃; for 8h; Product distribution;80%
benzyl bromide
100-39-0

benzyl bromide

3,4-dihydroxybenzaldehyde
139-85-5

3,4-dihydroxybenzaldehyde

A

3,4-dibenzyloxybenzaldehyde
5447-02-9

3,4-dibenzyloxybenzaldehyde

B

4-benzyloxy-3-hydroxy-benzaldehyde
4049-39-2

4-benzyloxy-3-hydroxy-benzaldehyde

C

3-benzyloxy-4-hydroxybenzaldehyde
50773-56-3

3-benzyloxy-4-hydroxybenzaldehyde

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 20 - 60℃; for 16h;A n/a
B 74%
C n/a
Stage #1: 3,4-dihydroxybenzaldehyde With sodium hydride In N,N-dimethyl-formamide; mineral oil at 0℃; for 0.5h; Inert atmosphere;
Stage #2: benzyl bromide In N,N-dimethyl-formamide; mineral oil at 0℃; for 0.75h; Inert atmosphere; regioselective reaction;
benzyl chloride
100-44-7

benzyl chloride

3,4-dihydroxybenzaldehyde
139-85-5

3,4-dihydroxybenzaldehyde

A

3,4-dibenzyloxybenzaldehyde
5447-02-9

3,4-dibenzyloxybenzaldehyde

B

4-benzyloxy-3-hydroxy-benzaldehyde
4049-39-2

4-benzyloxy-3-hydroxy-benzaldehyde

C

3-benzyloxy-4-hydroxybenzaldehyde
50773-56-3

3-benzyloxy-4-hydroxybenzaldehyde

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 80℃; for 24h;A 6%
B 50%
C 9%
3,4-dibenzyloxybenzoyl chloride
1486-54-0

3,4-dibenzyloxybenzoyl chloride

3,4-dibenzyloxybenzaldehyde
5447-02-9

3,4-dibenzyloxybenzaldehyde

Conditions
ConditionsYield
With quinoline; Pd-BaSO4; sulfur Hydrogenation.Reagens 4: Xylol;
3,4-bis(benzyloxy)-6-bromobenzaldehyde
4816-00-6

3,4-bis(benzyloxy)-6-bromobenzaldehyde

3,4-dibenzyloxybenzaldehyde
5447-02-9

3,4-dibenzyloxybenzaldehyde

Conditions
ConditionsYield
(i) LiAlH4, (ii) MnO2; Multistep reaction;
O,O-Dibenzyl-2-brom-protocatechualdehyd
4815-98-9

O,O-Dibenzyl-2-brom-protocatechualdehyd

3,4-dibenzyloxybenzaldehyde
5447-02-9

3,4-dibenzyloxybenzaldehyde

Conditions
ConditionsYield
(i) LiAlH4, (ii) MnO2; Multistep reaction;
benzyl chloride
100-44-7

benzyl chloride

3,4-dihydroxybenzaldehyde
139-85-5

3,4-dihydroxybenzaldehyde

A

3,4-dibenzyloxybenzaldehyde
5447-02-9

3,4-dibenzyloxybenzaldehyde

B

3-benzyloxy-4-hydroxybenzaldehyde
50773-56-3

3-benzyloxy-4-hydroxybenzaldehyde

Conditions
ConditionsYield
With sodium hydride 1.) DMF, 30 min, r.t., 2.) 24 h, 0 deg C; Yield given. Multistep reaction;
3,4-bis(benzyloxy)benzyl alcohol
1699-58-7

3,4-bis(benzyloxy)benzyl alcohol

3,4-dibenzyloxybenzaldehyde
5447-02-9

3,4-dibenzyloxybenzaldehyde

Conditions
ConditionsYield
With bis(1H-benzimidazolinium) dichromate In acetone for 0.0333333h; Heating;88 % Chromat.
With pyridinium chlorochromate In dichloromethane at 20℃;
4-benzyloxy-3-hydroxy-benzaldehyde
4049-39-2

4-benzyloxy-3-hydroxy-benzaldehyde

benzyl alcohol
100-51-6

benzyl alcohol

3,4-dibenzyloxybenzaldehyde
5447-02-9

3,4-dibenzyloxybenzaldehyde

Conditions
ConditionsYield
With triphenylphosphine; diethylazodicarboxylate In tetrahydrofuran at 23℃; for 5h; Mitsunobu reaction;
3,4-Dihydroxybenzoic acid
99-50-3

3,4-Dihydroxybenzoic acid

3,4-dibenzyloxybenzaldehyde
5447-02-9

3,4-dibenzyloxybenzaldehyde

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: H2SO4 / Heating
2: 86 percent / K2CO3 / dimethylformamide / 8 h / 75 °C
3: 94 percent / LiAlH4 / tetrahydrofuran / 0 - 20 °C
4: pyridinium chlorochromate / CH2Cl2 / 20 °C
View Scheme
Multi-step reaction with 3 steps
2: SOCl2
3: palladium/BaSO4; quinoline; sulfur / Hydrogenation.Reagens 4: Xylol
View Scheme
3,4-dihydroxybenzoic acid methyl ester
2150-43-8

3,4-dihydroxybenzoic acid methyl ester

3,4-dibenzyloxybenzaldehyde
5447-02-9

3,4-dibenzyloxybenzaldehyde

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 86 percent / K2CO3 / dimethylformamide / 8 h / 75 °C
2: 94 percent / LiAlH4 / tetrahydrofuran / 0 - 20 °C
3: pyridinium chlorochromate / CH2Cl2 / 20 °C
View Scheme
3,4-bis-benzyloxybenzoic acid methyl ester
54544-05-7

3,4-bis-benzyloxybenzoic acid methyl ester

3,4-dibenzyloxybenzaldehyde
5447-02-9

3,4-dibenzyloxybenzaldehyde

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 94 percent / LiAlH4 / tetrahydrofuran / 0 - 20 °C
2: pyridinium chlorochromate / CH2Cl2 / 20 °C
View Scheme
benzyl bromide
100-39-0

benzyl bromide

polymer-bound NMe3(1+)*SCN(1-)

polymer-bound NMe3(1+)*SCN(1-)

3,4-dibenzyloxybenzaldehyde
5447-02-9

3,4-dibenzyloxybenzaldehyde

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: NaH / dimethylformamide / 0.17 h / 0 °C
1.2: dimethylformamide / 12 h / 0 - 23 °C
2.1: PPh3; DEAD / tetrahydrofuran / 5 h / 23 °C
View Scheme
3,4-dihydroxybenzaldehyde
139-85-5

3,4-dihydroxybenzaldehyde

3,4-dibenzyloxybenzaldehyde
5447-02-9

3,4-dibenzyloxybenzaldehyde

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: NaH / dimethylformamide / 0.17 h / 0 °C
1.2: dimethylformamide / 12 h / 0 - 23 °C
2.1: PPh3; DEAD / tetrahydrofuran / 5 h / 23 °C
View Scheme
3,4-bis(benzyloxy)benzoic acid
1570-05-4

3,4-bis(benzyloxy)benzoic acid

3,4-dibenzyloxybenzaldehyde
5447-02-9

3,4-dibenzyloxybenzaldehyde

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: SOCl2
2: palladium/BaSO4; quinoline; sulfur / Hydrogenation.Reagens 4: Xylol
View Scheme
benzyl chloride
100-44-7

benzyl chloride

3,4-dibenzyloxybenzaldehyde
5447-02-9

3,4-dibenzyloxybenzaldehyde

Conditions
ConditionsYield
Multi-step reaction with 3 steps
2: SOCl2
3: palladium/BaSO4; quinoline; sulfur / Hydrogenation.Reagens 4: Xylol
View Scheme
isovanillin
621-59-0

isovanillin

3,4-dibenzyloxybenzaldehyde
5447-02-9

3,4-dibenzyloxybenzaldehyde

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: Br2, AcOH
2: AlCl3, Py
3: NaH
4: (i) LiAlH4, (ii) MnO2
View Scheme
Multi-step reaction with 4 steps
1: Br2, AcOH
2: AlCl3, Py
3: NaH
4: (i) LiAlH4, (ii) MnO2
View Scheme
2-bromoisovanillin
2973-59-3

2-bromoisovanillin

3,4-dibenzyloxybenzaldehyde
5447-02-9

3,4-dibenzyloxybenzaldehyde

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: AlCl3, Py
2: NaH
3: (i) LiAlH4, (ii) MnO2
View Scheme
2-bromoisovanillin
2973-58-2

2-bromoisovanillin

3,4-dibenzyloxybenzaldehyde
5447-02-9

3,4-dibenzyloxybenzaldehyde

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: AlCl3, Py
2: NaH
3: (i) LiAlH4, (ii) MnO2
View Scheme
2-bromo-4,5-dihydroxybenzoaldehyde
4815-99-0

2-bromo-4,5-dihydroxybenzoaldehyde

3,4-dibenzyloxybenzaldehyde
5447-02-9

3,4-dibenzyloxybenzaldehyde

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: NaH
2: (i) LiAlH4, (ii) MnO2
View Scheme
2-bromo-3,4-dihydroxybenzaldehyde
4815-97-8

2-bromo-3,4-dihydroxybenzaldehyde

3,4-dibenzyloxybenzaldehyde
5447-02-9

3,4-dibenzyloxybenzaldehyde

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: NaH
2: (i) LiAlH4, (ii) MnO2
View Scheme
(((4-bromo-1,2-phenyIene)bis(oxy))bis(methylene))dibenzene
16047-57-7

(((4-bromo-1,2-phenyIene)bis(oxy))bis(methylene))dibenzene

3,4-dibenzyloxybenzaldehyde
5447-02-9

3,4-dibenzyloxybenzaldehyde

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: N,N-dimethyl-formamide / 18 h / Reflux
2: diisobutylaluminium hydride / toluene / 3.5 h / -78 °C
View Scheme
benzyl bromide
100-39-0

benzyl bromide

3,4-dibenzyloxybenzaldehyde
5447-02-9

3,4-dibenzyloxybenzaldehyde

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: potassium carbonate / N,N-dimethyl-formamide
2.1: lithium aluminium tetrahydride / tetrahydrofuran / 0 °C
2.2: 0 - 20 °C
View Scheme
3,4-dibenzyloxybenzaldehyde
5447-02-9

3,4-dibenzyloxybenzaldehyde

diethoxyphosphoryl-acetic acid ethyl ester
867-13-0

diethoxyphosphoryl-acetic acid ethyl ester

3-(3,4-bis-benzyloxy-phenyl)-acrylic acid ethyl ester
203571-40-8

3-(3,4-bis-benzyloxy-phenyl)-acrylic acid ethyl ester

Conditions
ConditionsYield
Stage #1: diethoxyphosphoryl-acetic acid ethyl ester With sodium hydride In tetrahydrofuran
Stage #2: 3,4-dibenzyloxybenzaldehyde In tetrahydrofuran for 0.166667h; Further stages.;
100%
With sodium hydride In 1,2-dimethoxyethane for 0.333333h;99.5%
With sodium In ethanol Ambient temperature;76%
3,4-dibenzyloxybenzaldehyde
5447-02-9

3,4-dibenzyloxybenzaldehyde

o-hydroxyacetophenone
118-93-4

o-hydroxyacetophenone

(E)-3-(3',4'-bis(benzyloxy)phenyl)-1-(2-hydroxyphenyl)prop-2-en-1-one
1148010-41-6

(E)-3-(3',4'-bis(benzyloxy)phenyl)-1-(2-hydroxyphenyl)prop-2-en-1-one

Conditions
ConditionsYield
Stage #1: o-hydroxyacetophenone With sodium hydride In N,N-dimethyl-formamide; oil Claisen-Schmidt reaction; Cooling;
Stage #2: 3,4-dibenzyloxybenzaldehyde In N,N-dimethyl-formamide; oil at 2 - 20℃; for 4.83333h; Claisen-Schmidt reaction;
100%
With potassium hydroxide In methanol at 20℃; for 10h; Claisen-Schmidt condensation;62%
With sodium hydroxide In ethanol; water at 20 - 50℃;55%
3,4-dibenzyloxybenzaldehyde
5447-02-9

3,4-dibenzyloxybenzaldehyde

malonic acid dimethyl ester
108-59-8

malonic acid dimethyl ester

1,3-dimethyl 2-[3,4-bis(benzyloxy)benzylidene]malonate

1,3-dimethyl 2-[3,4-bis(benzyloxy)benzylidene]malonate

Conditions
ConditionsYield
With piperidine; acetic acid In toluene for 3h; Inert atmosphere; Reflux;100%
3,4-dibenzyloxybenzaldehyde
5447-02-9

3,4-dibenzyloxybenzaldehyde

3,4-bis(benzyloxy)benzyl alcohol
1699-58-7

3,4-bis(benzyloxy)benzyl alcohol

Conditions
ConditionsYield
With sodium tetrahydroborate In methanol at 20℃; for 1h;99%
With methanol; sodium tetrahydroborate at 0 - 20℃; Inert atmosphere;97.5%
With sodium tetrahydroborate In tetrahydrofuran at 23℃; for 4h;93%
3,4-dibenzyloxybenzaldehyde
5447-02-9

3,4-dibenzyloxybenzaldehyde

3-bromopropylamine hydrochloride
5003-71-4

3-bromopropylamine hydrochloride

N-[3′,4′-(dibenzyloxy)benzylidene]-3-bromopropan-1-amine
1415806-87-9

N-[3′,4′-(dibenzyloxy)benzylidene]-3-bromopropan-1-amine

Conditions
ConditionsYield
With sodium sulfate; triethylamine In chloroform at 20℃; for 22h;99%
3,4-dibenzyloxybenzaldehyde
5447-02-9

3,4-dibenzyloxybenzaldehyde

nitromethane
75-52-5

nitromethane

(E)-3,4-dibenzyloxy-β-nitrostyrene
1699-54-3

(E)-3,4-dibenzyloxy-β-nitrostyrene

Conditions
ConditionsYield
With ammonium acetate; acetic acid for 0.666667h; Henry reaction; Heating;98%
With ammonium acetate In acetic acid for 2h; Heating;95%
With ammonium acetate; acetic acid at 90℃; for 5h; Inert atmosphere;90%
With n-Pentylamine
With n-Pentylamine for 36h;
3,4-dibenzyloxybenzaldehyde
5447-02-9

3,4-dibenzyloxybenzaldehyde

malonic acid
141-82-2

malonic acid

(E)-3-(3,4-bis(benzyloxy)phenyl)acrylic acid
54429-62-8

(E)-3-(3,4-bis(benzyloxy)phenyl)acrylic acid

Conditions
ConditionsYield
With piperidine In pyridine at 80 - 90℃; for 3h; Condensation; decarboxylation; Knoevenagel-Doebner reaction;98%
With morpholine; acetic acid Knoevenagel condensation; Heating;90%
Stage #1: 3,4-dibenzyloxybenzaldehyde; malonic acid With piperidine; pyridine In 1,4-dioxane for 5h; Reflux;
Stage #2: With hydrogenchloride In 1,4-dioxane; water at 20℃;
85%
3,4-dibenzyloxybenzaldehyde
5447-02-9

3,4-dibenzyloxybenzaldehyde

succinic acid diethyl ester
123-25-1

succinic acid diethyl ester

C27H26O6

C27H26O6

Conditions
ConditionsYield
With sodium ethanolate In ethanol for 4h; Stobbe Condensation; Inert atmosphere; Reflux;98%
3,4-dibenzyloxybenzaldehyde
5447-02-9

3,4-dibenzyloxybenzaldehyde

1-(4,6-Bis-benzyloxy-2,3-dimethoxy-phenyl)-ethanone
204590-51-2

1-(4,6-Bis-benzyloxy-2,3-dimethoxy-phenyl)-ethanone

(Z)-1-(4,6-Bis-benzyloxy-2,3-dimethoxy-phenyl)-3-(3,4-bis-benzyloxy-phenyl)-propenone
204590-53-4

(Z)-1-(4,6-Bis-benzyloxy-2,3-dimethoxy-phenyl)-3-(3,4-bis-benzyloxy-phenyl)-propenone

Conditions
ConditionsYield
With potassium hydroxide In ethanol at 40℃; for 1.5h;97%
3,4-dibenzyloxybenzaldehyde
5447-02-9

3,4-dibenzyloxybenzaldehyde

diethyl <3,5-bis(benzyloxy)benzyl>phosphonate
33617-49-1

diethyl <3,5-bis(benzyloxy)benzyl>phosphonate

(E)-1-<3,4-bis(benzyloxy)phenyl>-2-<3,5-bis(benzyloxy)phenyl>ethene
150258-78-9

(E)-1-<3,4-bis(benzyloxy)phenyl>-2-<3,5-bis(benzyloxy)phenyl>ethene

Conditions
ConditionsYield
With sodium hydride In tetrahydrofuran at 0℃; for 1h; Wittig-Horner Reaction; Reflux;97%
With sodium methylate In N,N-dimethyl-formamide at 0℃; for 3h; Wittig-Horner reaction;
3,4-dibenzyloxybenzaldehyde
5447-02-9

3,4-dibenzyloxybenzaldehyde

ethylenediamine
107-15-3

ethylenediamine

1,2-bis(3,4-dibenzyloxybenzylideneamino)ethane

1,2-bis(3,4-dibenzyloxybenzylideneamino)ethane

Conditions
ConditionsYield
With air In ethanol for 3h; Reflux;97%
3,4-dibenzyloxybenzaldehyde
5447-02-9

3,4-dibenzyloxybenzaldehyde

3,4-bis(benzyloxy)phenyl formate
189082-97-1

3,4-bis(benzyloxy)phenyl formate

Conditions
ConditionsYield
With 3-chloro-benzenecarboperoxoic acid In dichloromethane for 12h; Ambient temperature;96%
With 3-chloro-benzenecarboperoxoic acid In dichloromethane for 12h; Ambient temperature;95%
With 3-chloro-benzenecarboperoxoic acid In dichloromethane at 0 - 20℃;
3,4-dibenzyloxybenzaldehyde
5447-02-9

3,4-dibenzyloxybenzaldehyde

Nitroethane
79-24-3

Nitroethane

1-(3,4-dibenzyloxyphenyl)-2-nitropropene
62932-96-1

1-(3,4-dibenzyloxyphenyl)-2-nitropropene

Conditions
ConditionsYield
With ammonium acetate for 17h; Heating;96%
With ammonium acetate for 5h; Reflux;
3,4-dibenzyloxybenzaldehyde
5447-02-9

3,4-dibenzyloxybenzaldehyde

2'-hydroxy-4',6'-bis(methoxymethoxy)acetophenone
65490-09-7

2'-hydroxy-4',6'-bis(methoxymethoxy)acetophenone

3-(3,4-bis(benzyloxy)phenyl)-1-(2-hydroxy-4,6-bis(methoxymethoxy)phenyl)propenone

3-(3,4-bis(benzyloxy)phenyl)-1-(2-hydroxy-4,6-bis(methoxymethoxy)phenyl)propenone

Conditions
ConditionsYield
With sodium hydride In N,N-dimethyl-formamide; mineral oil at 0 - 20℃; for 3h;96%
3,4-dibenzyloxybenzaldehyde
5447-02-9

3,4-dibenzyloxybenzaldehyde

methylamine
74-89-5

methylamine

3,4-dibenzyloxybenzylidenemethylamine
220627-61-2

3,4-dibenzyloxybenzylidenemethylamine

Conditions
ConditionsYield
In water for 3h; Ambient temperature;94%
3,4-dibenzyloxybenzaldehyde
5447-02-9

3,4-dibenzyloxybenzaldehyde

3,4-dibenzyloxybenzylidenemethylamine

3,4-dibenzyloxybenzylidenemethylamine

Conditions
ConditionsYield
With methylamine94%
3,4-dibenzyloxybenzaldehyde
5447-02-9

3,4-dibenzyloxybenzaldehyde

Trimethylenediamine
109-76-2

Trimethylenediamine

1,3-bis(3,4-dibenzyloxybenzylideneamino)propane

1,3-bis(3,4-dibenzyloxybenzylideneamino)propane

Conditions
ConditionsYield
With air In ethanol for 3h; Reflux;94%
3,4-dibenzyloxybenzaldehyde
5447-02-9

3,4-dibenzyloxybenzaldehyde

3,4-bis(benzyloxy)benzoic acid
1570-05-4

3,4-bis(benzyloxy)benzoic acid

Conditions
ConditionsYield
With potassium permanganate In water; acetone for 6.5h; Heating;93%
With jones reagent In acetone for 2h; Ambient temperature;93%
With dihydrogen peroxide
With potassium permanganate In acetone
With sodium chlorite; sodium dihydrogenphosphate dihydrate; 2-methyl-but-2-ene In water; acetonitrile; tert-butyl alcohol at 20℃; for 0.166667h; Inert atmosphere;
3,4-dibenzyloxybenzaldehyde
5447-02-9

3,4-dibenzyloxybenzaldehyde

1-(3,6-Bis-benzyloxy-2,4-dimethoxy-phenyl)-ethanone
175988-38-2

1-(3,6-Bis-benzyloxy-2,4-dimethoxy-phenyl)-ethanone

(E)-1-(3,6-Bis-benzyloxy-2,4-dimethoxy-phenyl)-3-(3,4-bis-benzyloxy-phenyl)-propenone

(E)-1-(3,6-Bis-benzyloxy-2,4-dimethoxy-phenyl)-3-(3,4-bis-benzyloxy-phenyl)-propenone

Conditions
ConditionsYield
With potassium hydroxide In ethanol at 50℃;93%
3,4-dibenzyloxybenzaldehyde
5447-02-9

3,4-dibenzyloxybenzaldehyde

methylamine
74-89-5

methylamine

3,4-Dibenzyloxy-N-methyl-benzylamin
214424-25-6

3,4-Dibenzyloxy-N-methyl-benzylamin

Conditions
ConditionsYield
Stage #1: 3,4-dibenzyloxybenzaldehyde; methylamine With titanium(IV) isopropylate In methanol at 20℃; for 5h;
Stage #2: With sodium tetrahydroborate In methanol at 20℃; for 2h;
93%
3,4-dibenzyloxybenzaldehyde
5447-02-9

3,4-dibenzyloxybenzaldehyde

tert-butyl diethylphosphonoacetate
27784-76-5

tert-butyl diethylphosphonoacetate

tert-butyl (E)-3-(3,4-dibenzyloxyphenyl)prop-2-enoate
911224-84-5

tert-butyl (E)-3-(3,4-dibenzyloxyphenyl)prop-2-enoate

Conditions
ConditionsYield
Stage #1: tert-butyl diethylphosphonoacetate With n-butyllithium In tetrahydrofuran; hexane at -78℃; for 0.5h; Horner-Wadsworth-Emmons reaction;
Stage #2: 3,4-dibenzyloxybenzaldehyde In tetrahydrofuran; hexane at -78 - 20℃; Further stages.;
93%
With n-butyllithium In tetrahydrofuran; hexane Horner-Wadsworth-Emmons reaction;81%
3,4-dibenzyloxybenzaldehyde
5447-02-9

3,4-dibenzyloxybenzaldehyde

2,4-bis(benzyloxy)acetophenone
22877-01-6

2,4-bis(benzyloxy)acetophenone

2',3,4,4'-tetrakis(benzyloxy)chalcone
4621-44-7

2',3,4,4'-tetrakis(benzyloxy)chalcone

Conditions
ConditionsYield
With potassium hydroxide In ethanol for 24h; Ambient temperature;92.1%
With barium hydroxide octahydrate In tetrahydrofuran; ethanol at 40℃; for 24h; Inert atmosphere;75%
3,4-dibenzyloxybenzaldehyde
5447-02-9

3,4-dibenzyloxybenzaldehyde

1-[2,4-bis(benzyloxy)-6-hydroxyphenyl]ethanone
18065-05-9

1-[2,4-bis(benzyloxy)-6-hydroxyphenyl]ethanone

(E)-1-(2,4-bis(benzyloxy)-6-hydroxyphenyl)-3-(3',4'-bis(benzyloxy)phenyl)prop-2-en-1-one
120980-04-3

(E)-1-(2,4-bis(benzyloxy)-6-hydroxyphenyl)-3-(3',4'-bis(benzyloxy)phenyl)prop-2-en-1-one

Conditions
ConditionsYield
Stage #1: 1-[2,4-bis(benzyloxy)-6-hydroxyphenyl]ethanone With sodium hydride In N,N-dimethyl-formamide; oil at 0 - 5℃; Claisen-Schmidt reaction;
Stage #2: 3,4-dibenzyloxybenzaldehyde In N,N-dimethyl-formamide; oil at 0 - 20℃; Claisen-Schmidt reaction;
92%
With sodium hydride In N,N-dimethyl-formamide at 0 - 20℃; for 1.66h;85.5%
3,4-dibenzyloxybenzaldehyde
5447-02-9

3,4-dibenzyloxybenzaldehyde

diethyl 3,5-dimethoxybenzylphosphonate
108957-75-1

diethyl 3,5-dimethoxybenzylphosphonate

5-[2-(3,4-dibenzyloxyphenyl)ethenyl]-1,3-dimethoxybenzene

5-[2-(3,4-dibenzyloxyphenyl)ethenyl]-1,3-dimethoxybenzene

Conditions
ConditionsYield
Stage #1: diethyl 3,5-dimethoxybenzylphosphonate With sodium hydride In tetrahydrofuran for 0.0833333h; Inert atmosphere;
Stage #2: 3,4-dibenzyloxybenzaldehyde In tetrahydrofuran for 1h; Inert atmosphere; Reflux;
92%
3,4-dibenzyloxybenzaldehyde
5447-02-9

3,4-dibenzyloxybenzaldehyde

aniline
62-53-3

aniline

N-(3,4-bis(benzyloxy)benzyl)aniline
1295581-86-0

N-(3,4-bis(benzyloxy)benzyl)aniline

Conditions
ConditionsYield
Stage #1: 3,4-dibenzyloxybenzaldehyde; aniline With sodium tris(acetoxy)borohydride; acetic acid In dichloromethane at 20℃; Inert atmosphere;
Stage #2: With sodium hydrogencarbonate In dichloromethane; water
92%

5447-02-9Relevant articles and documents

Catalytic δ-hydroxyalkynone rearrangement in the stereoselective total synthesis of centrolobine, engelheptanoxides A and C and analogues

Ahmad, Mohammad N.,Chopra, Sidharth,Fernandes, Rodney A.,Kumar, Praveen

, (2021/08/13)

A catalytic stereoselective total synthesis of centrolobine and engelheptanoxides A and C has been completed via a metal-free catalytic δ-hydroxyalkynone rearrangement to 2,3-dihydro-4H-pyran-4-one and diastereoselective hydrogenation to the all syn-2,4,6-trisubstituted pyran strategy. The onliest required chirality was introduced by Jacobsen kinetic resolution, which further directed the diastereoselective hydrogenation. A first stereoselective synthesis of engelheptanoxide A is also accomplished. The analogues and derivatives of centrolobine and engelheptanoxides prepared were evaluated for antitubercular activity against M. tuberculosis H37Rv ATCC 27294.

NOVEL AUTOPHAGY-TARGETING CHIMERA (AUTOTAC) COMPOUND, AND COMPOSITION FOR PREVENTING, ALLEVIATING, OR TREATING DISEASES THROUGH TARGET PROTEIN DEGRADATION COMPRISING SAME

-

Paragraph 0092-0093, (2021/06/03)

The present invention relates to a novel AUTOTAC chimeric compound in which a new p62 ligand and a target-binding ligand are connected by a linker, a stereoisomer, hydrate, solvate or prodrug thereof, and a pharmaceutical or food composition for the prevention or treatment of diseases by degrading the target protein including the same as an active ingredient. They can target specific proteins to adjust their concentrations, and can also deliver drugs and other small molecule compounds to lysosomes. The AUTOTAC chimeric compound according to the present invention can be usefully used as a pharmaceutical composition for the prevention, amelioration or treatment of various diseases by selectively eliminating specific proteins.

Synthesis of catechol derived rosamine dyes and their reactivity toward biogenic amines

Leite, Andreia,Martins, Rui C.,Monteiro-Silva, Filipe,Queirós, Carla,Rangel, Maria,Rodríguez, María T.,Rojo, María J.,Silva, Ana M. G.,Torroba, Tomás

, (2021/08/30)

Functional organic dyes play a key role in many fields, namely in biotechnology and medical diagnosis. Herein, we report two novel 2,3-and 3,4-dihydroxyphenyl substituted rosamines (3 and 4, respectively) that were successfully synthesized through a microwave-assisted protocol. The best reaction yields were obtained for rosamine 4, which also showed the most interesting photophysical properties, specially toward biogenic amines (BAs). Several amines including n-and t-butylamine, cadaverine, and putrescine cause spectral changes of 4, in UV–Vis and fluorescence spectra, which are indicative of their potential application as an effective tool to detect amines in acetonitrile solutions. In the gas phase, the probe response is more expressive for spermine and putrescine. Additionally, we found that methanolic solutions of rosamine 4 and n-butylamine undergo a pink to yellow color change over time, which has been attributed to the formation of a new compound. The latter was isolated and identified as 5 (9?aminopyronin), whose solutions exhibit a remarkable increase in fluorescence intensity together with a shift toward more energetic wavelengths. Other 9-aminopyronins 6a, 6b, 7a, and 7b were obtained from methanolic solutions of 4 with putrescine and cadaverine, demonstrating the potential of this new xanthene entity to react with primary amines.

Synthesis and characterisation of novel tricyclic and tetracyclic furoindoles: Biological evaluation as SAHA enhancer against neuroblastoma and breast cancer cells

Arndt, Greg M.,Bingul, Murat,Black, David Stc.,Cheung, Belamy B.,Kumar, Naresh,Marshall, Glenn M.

, (2021/09/28)

The dihydropyranoindole structures were previously identified as promising scaffolds for improving the anti-cancer activity of histone deacetylase inhibitors. This work describes the synthesis of related furoindoles and their ability to synergize with suberoylanilide hydroxamic acid (SAHA) against neuroblastoma and breast cancer cells. The nucleophilic substitution of hydroxyin-dole methyl esters with α-haloketones yielded the corresponding arylether ketones, which were subsequently cyclized to tricyclic and tetracyclic furoindoles. The furoindoles showed promising individual cytotoxic efficiency against breast cancer cells, as well as decent SAHA enhancement against cancer cells in select cases. Interestingly, the best IC50 value was obtained with the non-cyclized intermediate.

Synthesis and SARs of dopamine derivatives as potential inhibitors of influenza virus PAN endonuclease

Liao, Yixian,Ye, Yilu,Li, Sumei,Zhuang, Yilian,Chen, Liye,Chen, Jianxin,Cui, Zining,Huo, Lijian,Liu, Shuwen,Song, Gaopeng

, (2020/01/21)

Currently, influenza PAN endonuclease has become an attractive target for development of new drugs to treat influenza infections. Herein we report the discovery of new PAN endonuclease inhibitors derived from a chelating agent dopamine moiety. A series of dopamine amide derivatives and their conformationally constrained 1,2,3,4-tetrahydroisoquinoline-6,7-diol-based analogs were elaborated and assayed against influenza virus A/WSN/33 (H1N1). Most compounds exhibited moderate to excellent antiviral activities, generating a preliminary SARs. Among them, compounds 14 and 19 showed stronger anti-IAV activity compared with the reference Peramivir. Moreover, 14 and 19 demonstrated a concentration-dependent inhibition of PAN endonuclease based on both FRET assay and SPR assay. Docking studies were also performed to elucidate the binding mode of 14 and 19 with the PAN protein and to identify amino acids involved in their mechanism of action, which were well consistent with the biological data. This finding was beneficial to laying the foundation for the rational development of more effective PAN endonuclease inhibitors.

Method for preparing 3, 4-dihydroxyphenylethanol

-

Paragraph 0058; 0060; 0063; 0065, (2020/06/20)

The invention discloses a method for preparing 3, 4-dihydroxyphenylethanol, which comprises the following steps: (1) preparing benzyloxymethyltriphenylphosphorus chloride, (2) preparing 3.4-dibenzyloxy benzaldehyde, (3) preparing 1, 2-dibenzyloxy-4-(2-benzyloxyvinyl)benzene, and (4) preparing 3, 4-dihydroxyphenylethanol. Compared with the prior art, the method has the advantages that 1, raw materials and reagents used in the method are lower in toxicity, safer, cheaper, easier to obtain and convenient to store, and the raw materials and operation cost are greatly reduced, 2, the method has fewreaction steps, is convenient to operate, and is easier for large-scale production, and 3, the method does not generate high-toxicity three wastes, so that the environmental pollution is reduced, andthe ecological environment is protected. Meanwhile, the yield of the prepared product is high and can reach 90% or above.

Synthesis, characterization and biological evaluation of novel dihydropyranoindoles improving the anticancer effects of HDAC inhibitors

Arndt, Greg M.,Bingul, Murat,Black, David StC,Cheung, Belamy B.,Kumar, Naresh,Marshall, Glenn M.

, (2020/03/26)

The dihydropyranoindole scaffold was identified as a promising target for improving the anti-cancer activity of HDAC inhibitors from the preliminary screening of a library of compounds. A suitable methodology has been developed for the preparation of novel dihydropyranoindoles via the Hemetsberger indole synthesis using azido-phenylacrylates, derived from the reaction of corresponding alkynyl-benzaldehydes with methyl azidoacetate, followed by thermal cyclization in high boiling solvents. Anti-cancer activity of all the newly synthesized compounds was evaluated against the SH-SY5Y and Kelly neuroblastoma cells as well as the MDA-MB-231 and MCF-7 breast adenocarcinoma cell lines. Biological studies showed that the tetracyclic systems had significant cytotoxic activity at higher concentration against the neuroblastoma cancer cells. More importantly, these systems, at the lower concentration, considerably enhanced the SAHA toxicity. In addition to that, the toxicity of designated systems on the healthy human cells was found to be significantly less than the cancer cells.

Potent human dihydroorotate dehydrogenase inhibitory activity of new quinoline-4-carboxylic acids derived from phenolic aldehydes: Synthesis, cytotoxicity, lipophilicity and molecular docking studies

Petrovi?, Milena M.,Roschger, Cornelia,Chaudary, Sidrah,Zierer, Andreas,Mladenovi?, Milan,Jakovljevi?, Katarina,Markovi?, Violeta,Botta, Bruno,Joksovi?, Milan D.

, (2020/10/21)

A series of novel 2-substituted quinoline-4-carboxylic acids was synthesized by Doebner reaction starting from freely available protocatechuic aldehyde and vanillin precursors. Human dihydroorotate dehydrogenase (hDHODH) was recognised as a clear molecular target for these heterocycles. All compounds were also tested for their antiproliferative potential against three cancer cells (MCF-7, A549, A375) and one normal cell line (HaCaT) to evaluate the selective cytotoxicity. Quinoline derivatives 3f and 3g were identified as potent hDHODH inhibitors while 3k and 3l demonstrated high cytotoxic activity against MCF-7 and A375 cells and good selectivity. In addition, the logD7.4 values obtained by the experimental method were found to be in the range from ?1.15 to 1.69. The chemical structures of all compounds were confirmed by IR, NMR and elemental analysis. The compounds pharmacology on the molecular level was revealed by means of molecular docking, highlighting the structural differences that distinguish highly active from medium and low active hDHODH inhibitors.

Synthesis of cinnamic amide derivatives and their anti-melanogenic effect in α-MSH-stimulated B16F10 melanoma cells

Ullah, Sultan,Kang, Dongwan,Lee, Sanggwon,Ikram, Muhammad,Park, Chaeun,Park, Yujin,Yoon, Sik,Chun, Pusoon,Moon, Hyung Ryong

, p. 78 - 92 (2018/10/24)

Of the three enzymes that regulate the biosynthesis of melanin, tyrosinase and its related proteins TYRP-1 and TYRP-2, tyrosinase is the most important because of its ability to limit the rate of melanin production in melanocytes. For treating skin pigmentation disorders caused by an excess of melanin, the inhibition of tyrosinase enzyme is by far the most established strategy. Cinnamic acid is a safe natural product with an (E)-β-phenyl-α,β-unsaturated carbonyl motif that we have previously shown to play an important role in high tyrosinase inhibition. Since cinnamic acid is relatively hydrophilic, which hinders its absorption on the skin, fifteen less hydrophilic cinnamic amide derivatives (1–15) were designed as safe and more potent tyrosinase inhibitors and were synthesized through a Horner-Wadsworth-Emmons reaction. The use of conc-HCl and acetic acid for debenzylation of the O-benzyl-protected cinnamic amides 40–54 produced the following three results. 1) Cinnamic amides 43, 48, and 53 with a 2,4-dibenzyloxyphenyl group, irrespective of the amine type of the amides, produced complex compounds with high polarity. 2) Cinnamic amides 40–42, 44, 50–52, and 54 with a benzylamino, or diethylamino group produced the desired debenzylated cinnamic amides 1–3, 5, 10–13, and 15. 3) Cinnamic amides 45–47, and 49 with an anilino moiety provided 3,4-dihydroquinolinones 16–19 through intramolecular Michael addition of the anilide group. Notably, the use of BBr3 as an alternative debenzylating agent for debenzylation of cinnamic amides 45–49 with the anilino moiety provided our desired cinnamic amides 6–10 without inducing the intramolecular Michael addition. Debenzylation of cinnamic amides 43, 48, and 53 with a 2,4-dibenzyloxyphenyl group was also successfully accomplished using BBr3 to give 4, 9, and 14. Among the nine compounds that inhibited mushroom tyrosinase more potently at 25 μM than kojic acid, four cinnamic amides 4, 5, 9, and 14 showed 3-fold greater tyrosinase inhibitory activity than kojic acid. The docking simulation using tyrosinase indicated that these four cinnamic amides (?6.2 to ?7.9 kcal/mol) bind to the active site of tyrosinase with stronger binding affinity than kojic acid (?5.7 kcal/mol). All four cinnamic amides inhibited melanogenesis and tyrosinase activity more potently than kojic acid in α-MSH-stimulated B16F10 melanoma cells in a dose-dependent manner without cytotoxicity. The strong correlation between tyrosinase activity and melanin content suggests that the anti-melanogenic effect of cinnamic amides is due to tyrosinase inhibitory activity. Considering that the cinnamic amides 4, 9, and 14, which exhibited strong inhibition on mushroom tyrosinase and potent anti-melanogenic effect in B16F10 cells, commonly have a 2,4-dihydroxyphenyl substituent, the 2,4-dihydroxyphenyl substituent appears to be essential for high anti-melanogenesis. These results support the potential of these four cinnamic amides as novel and potent tyrosinase inhibitors for use as therapeutic agents with safe skin-lightening efficiency.

Tyrosinase inhibition and anti-melanin generation effect of cinnamamide analogues

Ullah, Sultan,Park, Chaeun,Ikram, Muhammad,Kang, Dongwan,Lee, Sanggwon,Yang, Jungho,Park, Yujin,Yoon, Sik,Chun, Pusoon,Moon, Hyung Ryong

, p. 43 - 55 (2019/03/11)

Abnormal melanogenesis results in excessive production of melanin, leading to pigmentation disorders. As a key and rate-limiting enzyme for melanogenesis, tyrosinase has been considered an important target for developing therapeutic agents of pigment disorders. Despite having an (E)-β-phenyl-α,β-unsaturated carbonyl scaffold, which plays an important role in the potent inhibition of tyrosinase activity, cinnamic acids have not attracted attention as potential tyrosinase inhibitors, due to their low tyrosinase inhibitory activity and relatively high hydrophilicity. Given that cinnamic acids’ structure intrinsically features this (E)-scaffold and following our experience that minute changes in the chemical structure can powerfully affect tyrosinase activity, twenty less hydrophilic cinnamamide derivatives were designed as potential tyrosinase inhibitors and synthesised using a Horner-Wadsworth-Emmons reaction. Four of these cinnmamides (4, 9, 14, and 19) exhibited much stronger mushroom tyrosinase inhibition (over 90% inhibition) at 25 μM compared to kojic acid (20.57% inhibition); crucially, all four have a 2,4-dihydroxy group on the β-phenyl ring of the scaffold. A docking simulation using tyrosinase indicated that the four cinnamamides exceeded the binding affinity of kojic acid, and bound more strongly to the active site of tyrosinase. Based on the strength of their tyrosinase inhibition, these four cinnamamides were further evaluated in B16F10 melanoma cells. All four cinnamamides, without cytotoxicity, exhibited higher tyrosinase inhibitory activity (67.33 – 79.67% inhibition) at 25 μM than kojic acid (38.11% inhibition), with the following increasing inhibitory order: morpholino (9) = cyclopentylamino (14) cyclohexylamino (19) N-methylpiperazino (4) cinnamamides. Analysis of tyrosinase activity and melanin content in B16F10 cells showed that the four cinnamamides dose-dependently inhibited both cellular tyrosinase activity and melanin content and that their inhibitory activity at 25 μM was much better than that of kojic acid. The results of melanin content analysis well matched those of the cellular tyrosinase activity analysis, indicating that tyrosinase inhibition by the four cinnamamides is a major factor in the reduction of melanin production. These results imply that these four cinnamamides with a 2,4-dihydroxyphenyl group can act as excellent anti-melanogenic agents in the treatment of pigmentation disorders.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 5447-02-9